Bill > S627

This bill aims to promote transparency in prescription drug prices. It has two key provisions: 1. The Health Policy Commission, in collaboration with the Center for Health Information and Analysis, will identify up to 15 prescription drugs annually that have seen significant price increases over the past 5 years or 12 months, or are new drugs that may have a significant impact on healthcare costs. The Commission will provide this information to the Office of the Attorney General, which can then require the drug's manufacturer to justify the price increase. 2. Manufacturers must report to the Health Policy Commission any planned price increase of 10% or more over a 12-month period for a prescription drug, or the introduction of a new drug that may threaten the state's healthcare cost benchmark. The report must include detailed information about the drug's pricing, development, and the manufacturer's finances and marketing expenses. The bill also empowers the Attorney General to take enforcement action, including civil penalties, against manufacturers that fail to provide the required information. The goal is to enhance transparency around prescription drug pricing in order to help control healthcare costs in the state.

Health and Social Services

https://malegislature.gov/Bills/190/S627